This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We’ve covered the pharmaceutical industry in depth before , but which brands are getting high engagement on Facebook and how has media covered them in 2019? Coverage of pharmaceutical companies has remained pretty consistent in the past few years, but engagement is lower in 2019. Pharmaceutical companies’ owned media.
Owen Cullen, Managing Director at Cullen Communications We are pleased to share the next post in a series of in-depth profiles of key international markets written by one of our PRGN partners. Other key industries include manufacturing, aerospace, medical devices, pharmaceuticals and renewable energy.
Oktavia has years of experience as a pharmaceuticalcommunications professional, so she has a firm grasp on how to walk the narrow path of FDA regulatory compliance. This outcome is confusing – even for a seasoned pharmaceutical PR Exec like Oktavia. Submission Requirements Under the FDA Guidance. .
Oktavia is a PR Exec for a large pharmaceutical company. Needless to say, Oktavia put the heat on her communications team to be ready to push out the story and get coverage the minute the FDA approves their drug. if you are a pharmaceuticalcommunications professional, you know Oktavia’s task list all too well.
He’ll have no time to review their sample medications and accompanying brochures, which is unfortunate: Pharmaceutical Company A manufactures Drug X, which would have been ideal for Little Johnny. and DON’T Be Pharmaceutical Company A. Yes, that’s historically accurate.
So it stands to reason that online marketing is subject to scrutiny. The Agency has already spoken on post-marketing reporting requirements via Guidance issued in January 2014. But reporting on your online pharmaceuticalcommunications is just one issue.
Pharmaceuticals PR teams are all-too-familiar with both: Facebook, the social media juggernaut you can’t ignore when promoting your brand; Instagram, the fun, kicky image and video sharing network. There’s no question that their combination of engagement and reach make them go-to tools for pharmaceuticalsmarketers.
I always make sure I have the right tools for my work in content marketing, so my error could easily have been avoided if I’d carried over that strategy. Social market research and brand tracking tools allow you to better manage reputation, identify threats and get a leg up over your competition. Periscope: Live Video Streaming.
From research to execution, every aspect of your communication strategy is important. Anthony Bianco, executive vice president and general manager at República, says brands need to invest in each component of communication to ensure success. How did you get your start in advertising and communication? Luck favors the prepared.
It’s Pharmaceutical PR 101: Speed matters in healthcare communications. So, if it’s all about the need for speed in the current communications landscape, why is pharma so slow to embrace social media promotions? Marketers know that social media isn’t just a trend: It’s indispensable to brand identity and product promotion.
Yes, it’s true that you’re a busy pharmaceuticalcommunications exec: Why would you add another online channel to your already-loaded pharma marketing toolkit ? Instagram content is consumable through quick captions, images, and video clips – unique content that communicates information about the products you offer.
Public relations and content marketing are powerful when they work together, particularly for B2B PR programs designed to educate prospective customers and push them down the funnel to a point of purchase. But when they work in concert, PR and content marketing are a 1+1+3 situation. Never discount earned media.
Like everything else in life, a move from agency PR to corporate or brand communications involves trade-offs. At an agency, “you have your finger on the pulse” of industry trends, according to Debbie Etchison, head of public affairs and corporate communications at a major pharmaceutical company. Constant innovation.
However, now that public relations is overlapping with marketing, you’d think demonstrating a return on investment (ROI) would be getting easier. If there’s anything marketing has a lot of, then it’s metrics. However, most recently, EMV is used to evaluate ROI for influencer marketing campaigns. EMV is a mysterious metric.
Since today’s best practices for pharmaceutical PR necessitates using multimedia content in communication s, we’re obviously not talking about just text. We’ll continue our Regulatory Series for pharmaceuticalcommunications and PR professionals with: The FDA Keeps Up with the Kardashians AND. Stay tuned….
Andy See Teong Leng – Perspective Strategies – Malaysia We are pleased to share the next post in a series of in-depth profiles of key international markets written by one of our PRGN partners. Malaysia is a dynamic market for Halal products and services and a world leader in Halal certification.
“I have lost business because I was a Black woman, but I’ve also gained business because I was a Black woman,” said LaTricia Woods, APR, owner of Mahogany Xan Communications in Chandler, Ariz. Companies are looking for authentic storytellers and authentic representation.”. Woods was one of four panelists during PRSA’s Feb.
Few marketers would dispute that pharma companies have been a bit slow to get on board with social media. We’ve covered various aspects of pharmaceuticalcommunications online a few times…. Since we’re big on “Top # Tips,” here are the Top 3 Ways Pharma Can Better Leverage Twitter in Marketing.
I have been following the vaccine trial development that a lot of pharmaceutical companies are undertaking right now. In other words, consumers will think that the pharmaceutical companies are being ineffective in their development. There’s a lot of things to watch on the news of late. That’s not necessarily the case.
While they may not have the thrills and chills of a heated boxing match, there are similar results when you put two PR communications solutions in the ring together: One solution will always outdo the other because it offers superior features– whether it saves you time, reduces costs or improves your campaign outcome.
While they may not have the thrills and chills of a heated boxing match, there are similar results when you put two PR communications solutions in the ring together: One solution will always outdo the other because it offers superior features– whether it saves you time, reduces costs or improves your campaign outcome.
While this information democracy era is still in its infancy, its promise of open, honest and ethical marketing and communication is encouraging. Gwen Chynoweth is executive vice president and chief talent officer at Minneapolis-based Maccabee , a strategic public relations and online marketing agency. Source: PRNewser ).
In our conversations we realized that when we approach our definition of clients as a question rather than an assumption, we discover opportunities to demonstrate the value of public relations beyond the communications team. Maybe it’s their boss, for instance. Determine wh a t your client wants out of their metrics.
There aren’t many pharmaceutical PR executives who would accuse the FDA of having a sense of humor. Just close your eyes and you can picture agents sitting around a conference table, laughing as they think of ways to make the daily grind of a healthcare communications pro more difficult. Read Time: 2 minutes.
As cold and flu season approaches, medical practices face increased patient volumes, heightened media attention, and the need for clear, consistent communication about health and wellness. A PR agency can help doctors and healthcare providers communicate preventive tips and best practices for managing cold and flu symptoms.
But aside from a crafty marketing scheme, we also recognize that posting FDA-compliant content on limited character platforms is a science – one that deserves a post all its own. To comply with FDA regulations, your Tweet – and any other pharmaceutical PR content – must properly balance risks and benefits. Stay tuned for the next.
We’ve already talked about how pharmaceuticalcommunications must equally balance risks and benefits in order to avoid being false or misleading. But Kim’s obvious omission in failing to communicate risk information isn’t the point here. The Harsh Consequences of a Little Tweet. .
And the flow of information from pharmaceutical enterprises is streaming at speeds never before seen. As a result, life science communications teams are creating and delivering compelling content for drug launches, unbranded campaigns, disease state awareness reports and more. And more frequently, it’s viewed on mobile devices.
However, it’s interesting and unexpected that pharmaceutical companies that are usually late social media adopters have already jumped on the Threads bandwagon (Boehringer Ingelheim, Moderna, Bayer and Amgen.) While this may limit immediate marketing capabilities, it also creates a significant PR opportunity.
And this is truly a scary story for marketing pros trying to get a grasp on global compliance issues related to pharmaceuticalcommunications: You’re about to meet the FDA’s not-quite-mirror-image twin, the European Medicines Agency (EMA). If granted, the centralized marketing authorization is valid in all EU member states. .
Lisa Martins, vice president at Finn Partners, says you must be open and honest with your audience and be mindful of what and how you are communicating with them. You’ve worked with some of the world’s largest pharmaceutical companies. So it’s important to be mindful and thoughtful of how you communicate. . healthful) lives.
Or – at the other end of the yardstick – a persistent and vast communications breakdown with costs in the millions gets ignored because it isn’t obvious to your stakeholders. Not only at enterprise scale – but at all scales, from minor bits of negative coverage to company-threatening market upheavals. Technology is wonderful.
Or – at the other end of the yardstick – a persistent and vast communications breakdown with costs in the millions gets ignored because it isn’t obvious to your stakeholders. Not only at enterprise scale – but at all scales, from minor bits of negative coverage to company-threatening market upheavals. Technology is wonderful.
It’s not every day the FDA issues a statement that amounts to pretty good news for pharmaceuticalscommunications teams. Obviously, mobile apps in the healthcare environment deserve the attention of pharma marketers, but there’s more to the story than just the numbers. Read Time: 2 minutes.
by David Hagenbuch - professor of Marketing at Messiah University - author of Honorable Influence - founder of Mindful Marketing As a Seinfeld fan, one of my favorite episodes is when George’s eye catches a piece of flying grapefruit, causing him to confuse everyone with his involuntary winking. Actually, several other $5.5
Results of a survey published January 26, 2017 by InCrowd, a provider of market intelligence for pharma marketing firms, might send a shiver down the spine of every marketer in the health and life sciences world. A ban…on ALL DTC marketing? So what is simplicity in marketing?
The former CEO of Turing Pharmaceuticals triggered public fury and became the poster boy for industry greed after Turing raised the price of an obscure drug 4000 percent. It’s just another sign that small details can communicate corporate values, and the top executive needs to pay attention. Optics matter.
The term “brand journalism” is a bit of a lightning rod term in the social media marketing business. But, they haven’t exactly been well-known for groundbreaking social media marketing or content marketing in the past. For some, it conjures up imagery of “advertorials” and “sponsored content.”
Some observations we noted: Marketing and PR aren’t making significant use of the new character limits. Vice President, Marketing Technology. Marketing and advertising. Pharmaceutical companies. appeared first on SHIFT Communications PR Agency - Boston | New York | San Francisco | Austin. Christopher S.
The pharmaceuticalcommunications team at Duchesnay was able to turn things around by sticking to their original strategy – with just a slight adjustment to the delivery. In marketing landscape where pharma companies are slow to embrace social media , Duchesnay proved it has hit its stride. Same Approach, New Tactic.
Trust plays a big role in modern commerce and communications. But…would you trust Amazon to deliver your pharmaceuticals? According to CNBC , Amazon is hiring to break into the multi-billion-dollar pharmacy market. It can be a fickle commodity, rising and falling based on your reputation.
If one primary role of a communicator is to be the conscious of the organization, then this is a good time to voice that consciousness. 1) The PR tech vendors comms pros recommend The 2020 JOTW Communications Survey identified the PR tech vendors most likely to be recommended. Here’s this month’s PR tech sum.
Zikmund and Babin (see, Essentials of Marketing Research ) warn against such pseudo-research, advising the practitioner to, “Walk away from the project if it appears that management strongly desires a predetermined opinion.” ” Making the case for a helping hand for public relations research.
This week’s blog post is written by our Public Relations Global Network partner, Christina Rytter, Founder of Scandinavian Communications in Copenhagen. Christina provides a detailed insight into the business and communications environment in Denmark and delivers valuable advice to businesses seeking to navigate her home market.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content